Congressional Report Updates Status of Cannabis Rescheduling and Hemp THC Ban

The latest update from the Congressional Research Service (CRS) shows that the path to federal marijuana reform is still a bit of a maze. While there’s a big push to move cannabis from Schedule I to Schedule III, researchers are now backing away from calling it a "likely" outcome. Even if it happens, they warn that rescheduling alone won't magically align state-legal markets with federal law without further action from Congress. On the hemp front, things are getting tighter, with new "total THC" testing rules set for November that could seriously shake up the availability of consumable cannabinoids.

For the everyday toker, this matters because it shows the federal government is still dragging its feet on full legalization. While state markets continue to thrive and youth usage is actually dropping, the "Schedule III" fix might be more of a band-aid than a cure. It’s a reminder that while we’ve come a long way, the fight for true federal clarity and protected access for both medical and recreational users is far from over.